ReviewBMC pulmonary medicine2025
A case of tracheobronchomegaly misdiagnosed as COPD: case report and literature review.
Review in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mounier-Kuhn syndrome incidentally diagnosed during the evaluation of atypical chest pain: CT findings and diagnostic challenges.Radiology case reports · 2026Article
- [Allergic bronchopulmonary aspergillosis-essential knowledge for radiology].Radiologie (Heidelberg, Germany) · 2026Review
- Congenital tracheobronchomegaly (Mounier-Kuhn syndrome) in a 70-year-old nonsmoking male: A rare presentation in a low-resource setting.Respiratory medicine case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundTracheobronchomegaly, also known as Mounier-Kuhn syndrome (MKS), is a rare congenital condition characterized by significant dilation of the trachea and main bronchi along with an abnormal wall structure. Diagnosis can be confirmed through computed tomography, pulmonary function tests, and diagnostic bronchoscopy. Currently, there is no curative treatment for MKS; thus, symptomatic and supportive care remain the primary therapeutic approaches. Early diagnosis, effective infection control, and individualized management are crucial for improving patient outcomes.
methodsThis case report describes a middle-aged woman who presented with chronic cough, expectoration, and wheezing. She had been misdiagnosed with chronic obstructive pulmonary disease (COPD) at a local hospital for an extended period and was subsequently referred to our institution for fiberoptic bronchoscopy, which confirmed the diagnosis of MKS. By reviewing the literature via PubMed, we conducted a retrospective analysis of 29 previously reported cases of MKS, including the present case, totaling 30 cases (21 males and 9 females), predominantly middle-aged and elderly individuals.
conclusionsBased on our literature review, the misdiagnosis rate of MKS remains high, often accompanied by significant diagnostic delays. Additionally, the proportion of secondary MKS cases has increased, challenging the traditional notion that MKS is exclusively congenital. Despite its rarity, clinicians should consider MKS in patients presenting with recurrent lower respiratory tract infections, abnormal tracheobronchial morphology., poor response to antibiotic therapy, or refractory COPD-like symptoms. Early imaging and bronchoscopic evaluations are essential to confirm the diagnosis and prevent delayed treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.